Have You Taken Covid Treatments?


In recent months, the Biden administration has pointed to Covid therapeutics, including the antiviral pill Paxlovid, as a critical part of its strategy to fight the coronavirus pandemic, but there is some evidence that some Americans do not have easy access to the treatment or are not seeking it out.

The New York Times is interested in hearing from people about their experience of trying to get Paxlovid and other therapeutics (including monoclonal antibodies and Lagevrio) as well as from those who have avoided these treatments. Was it easy to get the pills? Did you run into barriers? Did you have trouble proving you were eligible for a treatment? Or did you avoid Paxlovid or other therapeutics for some reason?

Please answer the questions below. A Times reporter or editor may contact you to hear more about your story. We will not publish your name without your permission.

We are one of the biggest News outlets in all of Asia, we provide unbiased news without any agenda to any country, follow us for more real news.


Please enter your comment!
Please enter your name here

Share post:




More like this

India cenbank tightens scrutiny over digital lending apps

MUMBAI : The Reserve Bank...

Waking up from the Japanese debt dream

Affordability matters for government debt because the burden is...

Feng Tianwei arrives at Changi Airport to cheers from around 100 supporters

SINGAPORE: A sea of supporters erupted in a raucous...

‘Daddy Issues is playing’: Young people simp over 56-year-old silver fox Adrian Pang

Every year, the National Day Parade (NDP) brings us...